Human Genome Epidemiology Literature Finder
|
Records 1 - 5 (of 5 Records) |
| Query Trace: Cholangiocarcinoma and MDM2[original query] |
|---|
| Potential genotype-specific single nucleotide polymorphism interaction of common variation in p53 and its negative regulator mdm2 in cholangiocarcinoma susceptibility. Oncology letters 2012 Jul 4 (1): 101-106. Zimmer Vincent, Höblinger Aksana, Mihalache Florentina, Assmann Gunter, Acalovschi Monica, Lammert Fra |
| MDM2 SNP309 is an ethnicity-dependent risk factor for digestive tract cancers. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Apr 35 (4): 3431-8. Chen Bo, Cao Lei, Hu Kong-Wang, Zhang Jia-Wei, Meng Xiang-Ling, Xiong Mao-Mi |
| Target molecular treatment markers in Intrahepatic Cholangiocarcinoma based on Chinese population. Pathology, research and practice 2020 Sep 216 (9): 153116. Pu Xiaohong, Zhu Liya, Li Feng, Zheng Jinyu, Wu Hongyan, Fu Yao, Chen Jun, Qi Lia |
| Comprehensive analysis of genomic alterations of Chinese hilar cholangiocarcinoma patients. International journal of clinical oncology 2021 Jan . Feng Feiling, Wu Xiaobing, Shi Xiaoliang, Gao Qingxiang, Wu Yue, Yu Yong, Cheng Qingbao, Li Bin, Yi Bin, Liu Chen, Hao Qing, Zhang Lin, Gao Chunfang, Jiang Xiaoqi |
| Specific genomic alterations and prognostic analysis of perihilar cholangiocarcinoma and distal cholangiocarcinoma. Journal of gastrointestinal oncology 2021 Dec 12 (6): 2631-2642. Zheng Yuanwen, Qin Yejun, Gong Wei, Li Hongguang, Li Bin, Wang Yu, Chao Baoting, Zhao Shulei, Liu Luguang, Yao Shuzhan, Shi Junping, Shi Xiaoliang, Wang Kai, Xu Shife |
- Page last reviewed:Feb 1, 2024
- Content source: